Eli Lilly and Company (NYSE: LLY) today announced updated results from the Phase 3 EMBER-3 study of Inluriyo (imlunestrant), an oral estrogen receptor antagonist, in patients with estrogen receptor ...
To revamp the old system, the agency put down an initial $12.5 billion and awarded a contract to technology firm Peraton, ...
The final outcome is contingent on whether the police and fire pension board also agree to the funding agreement and decide ...
Annual Meeting, held December 6-9, 2025, in Orlando, Florida, showcased groundbreaking clinical advances in multiple myeloma ...
Insiders, however, paint a different picture, alleging the directors, facing the likelihood of no term extensions chose a dramatic exit to shape the narrative in their favor. In a theatrical exit that ...
European Union officials are finalizing a major overhaul of its migration system, including streamlined deportations and ...
Ubuntu MATE uses the MATE desktop (which is lightweight yet full-featured), which makes it easy for new users to hop onto the Linux bandwagon. MATE is as easy as it gets, with a bottom panel, a top ...
Researchers at Beijing Tiantan Hospital analyzed 101 glioma cases involving the brain’s motor pathway and found that ...
(GLOBE NEWSWIRE) -- (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced that ...